In other countries
The same active substances on other registers, the same brand first.
- Ayvakyt 100 MG Comprimidos Recubiertos con PeliculaSpain · 100 mg · comprimido recubierto con película · Blueprint Medicines (Netherlands) B.V.Same brand
- Ayvakyt 200 MG Comprimidos Recubiertos con PeliculaSpain · 200 mg · comprimido recubierto con película · Blueprint Medicines (Netherlands) B.V.Same brand
- Ayvakyt 25 MG Comprimidos Recubiertos con PeliculaSpain · 25 mg · comprimido recubierto con película · Blueprint Medicines (Netherlands) B.V.Same brand
- AyvakytEuropean Union · Blueprint Medicines (Netherlands) B.V.Same brand
- AyvakytCroatiaSame brand
- AyvakytItaly · Compressa rivestita con film · Blueprint Medicines (Netherlands) BVSame brand
- Ayvakyt 100 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Blueprint Medicines (Netherlands) B.V.Same brand
- Ayvakyt 200 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Blueprint Medicines (Netherlands) B.V.Same brand
- Ayvakyt 25 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Blueprint Medicines (Netherlands) B.V.Same brand
- AyvakitUnited States · 100MG, 200MG, 25MG … · tablet · Blueprint MedicinesSame form
- AYVAKIT film-coated tablets 100mgTaiwan · 膜衣錠 · 臺灣基石藥業有限公司Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Avapritinib
- Strength
- 25 MG
- Dosage form
- Tablet
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 2 Dec 2024
- Registration
- DIN 02551764
- Marketing authorisation holder
- Blueprint Medicines Corporation
- ATC code
- L01EX18
- Supply
- PRESCRIPTION